Arkos Global Advisors’s Pfizer PFE Stock Holding History

Arkos Global Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,010	Closed	-$56K	–	182
2026 Q1	$56K	Buy	+2,010	New	+$53.5K	0.01%	177
2023 Q3	–	Sell	-5,543	Closed	-$203K	–	107
2023 Q2	$203K	Buy	5,543 +10	+0.2%	+$389	0.04%	99
2023 Q1	$226K	Buy	5,533 +1,557	+39%	+$67.2K	0.05%	85
2022 Q4	$204K	Buy	+3,976	New	+$191K	0.05%	90
2022 Q3	–	Sell	-5,612	Closed	-$294K	–	94
2022 Q2	$294K	Buy	5,612 +1,024	+22%	+$52.2K	0.08%	64
2022 Q1	$237K	Buy	4,588 +564	+14%	+$29.3K	0.06%	82
2021 Q4	$238K	Sell	4,024 -700	-15%	-$34.7K	0.07%	80
2021 Q3	$203K	Buy	+4,724	New	+$209K	0.07%	86
2021 Q2	–	Sell	-6,187	Closed	-$224K	–	95
2021 Q1	$224K	Buy	6,187 +110	+2%	+$3.91K	0.09%	77
2020 Q4	$224K	Sell	6,077 -328	-5%	-$12K	0.09%	74
2020 Q3	$223K	Sell	6,405 -4,861	-43%	-$170K	0.1%	73
2020 Q2	$350K	Hold	11,266	–	–	0.18%	59
2020 Q1	$349K	Buy	+11,266	New	+$384K	0.23%	47

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arkos Global Advisors's PFE Position: Q2 2026 in Review

Arkos Global Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 2,010 shares — an estimated $56K sold.

Arkos Global Advisors first reported a position in PFE in Q1 2020 and held it in 13 quarters. The position peaked at $350K in Q2 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Arkos Global Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Arkos Global Advisors sold 2,010 Pfizer shares in Q2 2026, an estimated $56K.
Arkos Global Advisors first reported a position in Pfizer in Q1 2020 and held it in 13 quarters.
Arkos Global Advisors's Pfizer position peaked at $350K in Q2 2020.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.